Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT Alternate Symbol(s):  V.TLT.W

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:TLT)

Cancer-fighting pharma stock eyes 2027 regulatory approval

Trevor Abes  4 days ago

Theralase(R) Expands Clinical Team

Accesswire 4 days ago

Theralase advances cancer research after private placement

Jonathon Brown 12 days ago

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

Accesswire 12 days ago

This company’s Photo Dynamic Therapy is transforming cancer treatment

Jocelyn Aspa April 9, 2024

Theralase patents new cancer vaccine in Canada

Trevor Abes  April 5, 2024

Theralase(R) Granted Canadian Cancer Vaccine Patent

Accesswire April 5, 2024

Theralase(R) Release's 4Q2023 Interim Financial Statements

Accesswire March 27, 2024

Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association

Accesswire March 26, 2024
View More News ››

Opinion & Analysis (TSXV:TLT)

Pharmaceutical company treats bladder cancer with new tech

Ryan Dhillon January 8, 2024

Theralase is raising up to $5.3M to complete bladder cancer study

Coreena Robertson November 6, 2023

For Better or Worse? On the Verge of a New Era in Investing

Stockhouse Editorial April 1, 2021

Buzz on the Bullboards: A Big Picture Look at Small-Cap Opportunities

Stockhouse Editorial February 18, 2021

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Buzz on the Bullboards: T’is the Season for a Rebound?

Stockhouse Editorial December 3, 2020
View More Opinion ››

Bullboard Posts (TSXV:TLT)

RE:Chemotherapy drugs in short supply, needing new solutions

So easy; TLD-1466. Cancer gone; no harm to patient. Doctor office visit. Alamir4's correct; 10 billion start. @ 1.37 mil now.
DeathXray33 - 7 hours ago

Chemotherapy drugs in short supply, needing new solutions

https://link.biopharmadive.com/click/35281528.98004...
O12009 - 8 hours ago

RE:RE:Adstiladrin Five Year Data Is Out

My same thought BlueFrankey, no insider buys this last PP, something cooking, possible insider info prevented buys??? we should hear...
Legit62 - 8 hours ago

RE:Adstiladrin Five Year Data Is Out

Thanks Eog.. great post! You just got to believe that the recent hires are  all hands on deck/nose to the grindstone, helping to...
BlueFranky - 10 hours ago

RE:Adstiladrin Five Year Data Is Out

Great share Eog. That boggles the mind. That many instillations to 107 patients and only 6 get to be considered home free of the cancer....
DJDawg - 10 hours ago

RE:RE:RE:latest news release

You could always ask her - kaouthar.lbiati@gmail.com She may not be at liberty to share much information. I would guess she is...
gebremeskel - 10 hours ago
View more Bullboard ››

Trillion Energy International Inc.

Trillion Energy International Inc.

Trillion Energy International Inc. is a Canada-based oil and gas producing company that strives to maximize shareholder value ...
View More »